Company

VRG Therapeutics Kft.

VRG Therapeutics develops miniprotein-based biopharmaceuticals for cancer and other diseases.

About

Founded in 2021, VRG Therapeutics develops biopharmaceuticals using its miniprotein ISEP technology, with research focused on cancer, central nervous system disorders, autoimmune diseases, and other conditions. The company is based in Budapest, Hungary, and is led by CEO Zalan Peterfi. In August 2023, it raised EUR 5 million in Series A funding led by Széchenyi Capital Fund Management, with Vascular Venture participating.

1Funding rounds

2Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in